MENU
SPRO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Spero Therapeutics (SPRO) Ownership - Who owns Spero Therapeutics?
Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
675 Massachusetts Avenue
Phone
+1 857 242-1600
Employees
46
Web
https://www.sperotherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
143.41M
P/E Ratio
10.75
Total Cash
76.29M
Projected Growth
N/A
Total Debt
4.62M
Revenue
89.87M
Risk (Beta)
-0.72
Dividend Yield
N/A
Total Cash/Share
1.36
Total Debt/Equity
N/A
Revenue/Share
0.52 USD as % of share price
Fundamentals
SPRO
Capitalization
143M
P/E Ratio
10.75
Risk (Beta)
-0.72
Dividend Yield
N/A
Total Cash
76.3M
Total Cash/Share
1.36
Total Debt
4.62M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.52%
Revenue
89.9M
ROE
N/A
Book Value
65.5M
P/B Ratio
4.24
Cash Flow
N/A
Earnings
0.08
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
54K
Current Ratio
2.68
Current Revenue Per Employee
169978.27
Dividends Per Share - Security
N/A
EBITDA
-2.45M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
2.90
Shares Held By Institutions
16.8M
Shares Outstanding - Current
55.9M
Total Liabilities
69.7M
Total Volume MTD
N/A
Value
N/A
Gain YTD
149.029
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of novel therapies for the treatment of resistant bacterial infections
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
675 Massachusetts Avenue
Phone
+1 857 242-1600
Employees
46
Web
https://www.sperotherapeutics.com